title: Encephalopathy associated with OKT3 administration. Possible interaction with indomethacin.
authors.affiliation: Department of Pharmacotherapy and Research, Tampa General Hospital, Florida.
authors.forename: G L
authors.initials: GL
authors.lastname: Chan
authors.forename: S S
authors.initials: SS
authors.lastname: Weinstein
authors.forename: C E
authors.initials: CE
authors.lastname: Wright
authors.forename: V D
authors.initials: VD
authors.lastname: Bowers
authors.forename: D Y
authors.initials: DY
authors.lastname: Alveranga
authors.forename: D L
authors.initials: DL
authors.lastname: Shires
authors.forename: J R
authors.initials: JR
authors.lastname: Ackermann
authors.forename: W W
authors.initials: WW
authors.lastname: LeFor
authors.forename: L
authors.initials: L
authors.lastname: Kahana
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D001927:Brain Diseases / Q000209:etiology*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage* / Q000009:adverse effects; D016030:Kidney Transplantation; D001523:Mental Disorders / Q000209:etiology*; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D007213:Indomethacin